DEC 02, 2019 5:41 PM PST

Self-renewing blood stem cells give hope for blood disease treatments

New research details how activating a certain protein may be the key to getting hematopoietic stem cells (HSCs) to self-renew. The research comes from scientists at UCLA and was published recently in Nature. Its findings may open doorways for leukemia treatment, as well as other blood diseases.

HSCs are blood stem cells found in the bone marrow that make blood by differentiating into cells like red blood cells, T and B lymphocytes, and white blood cells. HSCs play an infinitely important role in making billions of new blood cells in the human body every day.

But for people with blood diseases, HSCs are necessary to make new blood cells, a demand which has typically been met with a supply of bone marrow. However, due to the array of difficulties that come along with bone marrow transplants, some researchers have been looking into using cultured HSCs to replace bone marrow transplants. Yet, they keep on getting stumped because HSCs lose their capacity for self-renewal in cultures soon after being removed from bone marrow.

"Although we've learned a lot about the biology of these cells over the years, one key challenge has remained: making [HSCs] self-renew in the lab. We have to overcome this obstacle to move the field forward," explains senior study author Hanna K. A. Mikkola, a professor of molecular, cell, and developmental biology at UCLA.

That’s why this study’s finding of a protein called MLLT3 is so noteworthy. Mikkola and her team found that manipulating MLLT3 resulted in a "more than 12-fold expansion of transplantable" HSCs. "If we think about the amount of blood stem cells needed to treat a patient, that's a significant number," commented Mikkola. The researchers plan to continue working on their process with MLLT3 in order to move from animal trials to human trials.

Sources: Nature, Medical News Today

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAY 02, 2020
Drug Discovery & Development
Glioblastoma Treatment Using Schizophrenic Drug Plus Radiation
MAY 02, 2020
Glioblastoma Treatment Using Schizophrenic Drug Plus Radiation
A therapeutic used for the treatment of schizophrenia could be a gateway for targeting glioblastoma, one of the deadlies ...
MAY 13, 2020
Cell & Molecular Biology
Combined with Fasting-Mimicking Diet, Vitamin C May Have Anti-Cancer Effect
MAY 13, 2020
Combined with Fasting-Mimicking Diet, Vitamin C May Have Anti-Cancer Effect
People have long been searching for natural ways to treat cancer in an effort to avoid some of the harmful side effects ...
MAY 21, 2020
Cancer
A New Player in the Regulation of Cancer's Microenvironment
MAY 21, 2020
A New Player in the Regulation of Cancer's Microenvironment
Breast cancer is one of the most common cancers in the world.  Triple-negative breast cancer (TNBC) is a sub-type o ...
JUN 12, 2020
Cancer
Reserach on APOBEC3A opens the way for new treatment targets
JUN 12, 2020
Reserach on APOBEC3A opens the way for new treatment targets
New research identifies how a protein, APOBEC3A, triggers genetic changes that result in various cancers. This expansion ...
JUN 29, 2020
Cancer
Mass Spectrometry and How It Can Profile Cancer
JUN 29, 2020
Mass Spectrometry and How It Can Profile Cancer
Treatments for cancer usually revolve around targeting certain immune checkpoints in the cell. Protein cell death protei ...
JUL 02, 2020
Cancer
Common hypertension medicine may reduce risk of colorectal cancer
JUL 02, 2020
Common hypertension medicine may reduce risk of colorectal cancer
There is hope that ACE inhibitors and ARBs, medications that are commonly prescribed for high blood pressure, may be hel ...
Loading Comments...